Effect of acute and chronic psychostimulant drugs on redox status, AP-1 activation and pro-enkephalin mRNA in the human astrocyte-like U373 MG cells

Neuropharmacology. 2005 Apr;48(5):673-84. doi: 10.1016/j.neuropharm.2004.12.010.

Abstract

In order to approach the astroglial implication of addictive and neurotoxic processes associated with psychostimulant drug abuse, the effects of amphetamine or cocaine (1-100 microM) on redox status, AP-1 transcription factor and pro-enkephalin, an AP-1 target gene, were investigated in the human astrocyte-like U373 MG cells. We demonstrated an early increase in the generation of radical oxygen species and in the formation of 4-hydroxynonenal-adducts reflecting the pro-oxidant action of both substances. After 1 h or 96 h of treatment, Fos and Jun protein levels were altered and the DNA-binding activity of AP-1 was increased in response to both substances. Using supershift experiments, we observed that the composition of AP-1 dimer differed according to the substance and the duration of treatment. FRA-2 protein represented the main component of the chronic amphetamine- or cocaine-activated complexes, which suggests its relevance in the long-term effects of psychostimulant drugs. Concomitantly, the pro-enkephalin gene was differently regulated by either 6 h or 96 h of treatment. Because astrocytes interact extensively with the neurons in the brain, our data led us to conclude that oxidation-regulated AP-1 target genes may represent one of the molecular mechanisms underlying neuronal adaptation associated with psychostimulant dependence.

Publication types

  • Comparative Study

MeSH terms

  • Amino Acid Transport System X-AG / genetics
  • Amino Acid Transport System X-AG / metabolism
  • Amphetamine / pharmacology*
  • Analysis of Variance
  • Astrocytes / drug effects*
  • Blotting, Western / methods
  • Cell Line
  • Central Nervous System Agents / pharmacology*
  • Cocaine / pharmacology*
  • DNA-Binding Proteins / metabolism
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Electrophoretic Mobility Shift Assay / methods
  • Enkephalins / genetics
  • Enkephalins / metabolism*
  • Excitatory Amino Acid Transporter 2 / genetics
  • Excitatory Amino Acid Transporter 2 / metabolism
  • Fluoresceins
  • Fos-Related Antigen-2
  • Gene Expression Regulation / drug effects
  • Glial Fibrillary Acidic Protein / metabolism
  • Humans
  • Oxidation-Reduction / drug effects
  • Protein Precursors / genetics
  • Protein Precursors / metabolism*
  • Proto-Oncogene Proteins c-fos / metabolism
  • Proto-Oncogene Proteins c-jun / metabolism
  • RNA, Messenger / metabolism
  • Reactive Oxygen Species / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Tetrazolium Salts
  • Thiazoles
  • Time Factors
  • Transcription Factor AP-1 / metabolism*
  • Transcription Factors / metabolism

Substances

  • Amino Acid Transport System X-AG
  • Central Nervous System Agents
  • DNA-Binding Proteins
  • Enkephalins
  • Excitatory Amino Acid Transporter 2
  • FOSL2 protein, human
  • Fluoresceins
  • Fos-Related Antigen-2
  • Glial Fibrillary Acidic Protein
  • Protein Precursors
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-jun
  • RNA, Messenger
  • Reactive Oxygen Species
  • Tetrazolium Salts
  • Thiazoles
  • Transcription Factor AP-1
  • Transcription Factors
  • fos-related antigen 1
  • proenkephalin
  • diacetyldichlorofluorescein
  • Amphetamine
  • thiazolyl blue
  • Cocaine